Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

Rutkowski P, Andrzejuk J, Bylina E, Osuch C, Switaj T, Jerzak vel Dobosz A, Grzesiakowska U, Jurkowska M, Woźniak A, Limon J, Dębiec-Rychter M, Siedlecki JA.

Med Oncol. 2013 Dec;30(4):765. doi: 10.1007/s12032-013-0765-7. Epub 2013 Nov 12.

PMID:
24217870
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.

Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J.

BMC Cancer. 2012 Mar 22;12:107. doi: 10.1186/1471-2407-12-107.

PMID:
22439647
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone.

Ruka W, Rutkowski P, Morysiński T, Nowecki Z, Zdzienicki M, Makula D, Ptaszyński K, Bylina E, Grzesiakowska U.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):494-8. doi: 10.1016/j.ijrobp.2009.07.1704. Epub 2009 Dec 11.

PMID:
20004531
[PubMed - indexed for MEDLINE]
4.

Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.

Ruka W, Rutkowski P, Szawłowski A, Nowecki Z, Debiec-Rychter M, Grzesiakowska U, Dziewirski W, Siedlecki JA, Michej W.

Eur J Surg Oncol. 2009 Jan;35(1):87-91. doi: 10.1016/j.ejso.2008.01.003. Epub 2008 Mar 4.

PMID:
18289826
[PubMed - indexed for MEDLINE]
5.

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.

Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.

Med Sci Monit. 2007 Nov;13(11):CR515-522.

PMID:
17968300
[PubMed - indexed for MEDLINE]
6.

Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.

Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Woźniak A, Limon J, Siedlecki J, Grzesiakowska U, Kakol M, Osuch C, Polkowski M, Głuszek S, Zurawski Z, Ruka W.

Ann Surg Oncol. 2007 Jul;14(7):2018-27. Epub 2007 May 2.

PMID:
17473953
[PubMed - indexed for MEDLINE]
7.

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).

Rutkowski P, Nowecki ZI, Debiec-Rychter M, Grzesiakowska U, Michej W, Woźniak A, Siedlecki JA, Limon J, vel Dobosz AJ, Kakol M, Osuch C, Ruka W.

J Cancer Res Clin Oncol. 2007 Sep;133(9):589-97. Epub 2007 Apr 26.

PMID:
17458563
[PubMed - indexed for MEDLINE]
8.

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.

Rutkowski P, Nowecki Z, Nyckowski P, Dziewirski W, Grzesiakowska U, Nasierowska-Guttmejer A, Krawczyk M, Ruka W.

J Surg Oncol. 2006 Mar 15;93(4):304-11.

PMID:
16496358
[PubMed - indexed for MEDLINE]
9.

The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).

Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W.

Neoplasma. 2003;50(6):438-42.

PMID:
14689066
[PubMed - indexed for MEDLINE]
10.
11.

[Osteoblastic periosteal dysplasia: clinical and radiologic characteristics].

Grzesiakowska U.

Pol Przegl Radiol. 1988 Jul-Oct;52(4-5):205-8. Polish. No abstract available.

PMID:
3076641
[PubMed - indexed for MEDLINE]
12.

[Osteoblastic neoplastic and neoplasm-like bone changes. II. Osteoblastoma and its place in the classification].

Grzesiakowska U.

Pol Przegl Radiol. 1987 Mar-Apr;51(2-3):103-7. Polish. No abstract available.

PMID:
3330198
[PubMed - indexed for MEDLINE]
13.

[Osteoblastic neoplastic or neoplasm-like bone changes. I. Osteoid osteoma: dysplasia or neoplasm?].

Grzesiakowska U.

Pol Przegl Radiol. 1987 Jan-Feb;51(1):4-8. Polish. No abstract available.

PMID:
3317302
[PubMed - indexed for MEDLINE]
14.

[Osteopoikilosis--a rare developmental anomaly and its significance in clinical oncology].

Grzesiakowska U, Smorczewska M.

Pol Przegl Radiol. 1985 May-Jun;49(3):161-4. Polish. No abstract available.

PMID:
3915066
[PubMed - indexed for MEDLINE]
15.

[Radiological findings in primary vascular malignant bone neoplasms].

Grzesiakowska U.

Nowotwory. 1983 Oct-Dec;33(4):355-60. Polish. No abstract available.

PMID:
6687008
[PubMed - indexed for MEDLINE]
16.

[Multiple non-metastatic malignant bone neoplasms. Problems, classification and description of 14 cases].

Buraczewski J, Dziukowa J, Grzesiakowska U.

Pol Przegl Radiol. 1983 Jul-Aug;47(4):283-8. Polish. No abstract available.

PMID:
6377265
[PubMed - indexed for MEDLINE]
17.

[Laryngocele coexisting with neoplasms of the larynx and pharynx].

Grzesiakowska U, Buraczewski J, Dziukowa J.

Otolaryngol Pol. 1982;36(4):193-8. Polish. No abstract available.

PMID:
7177653
[PubMed - indexed for MEDLINE]
18.

[Radiographic image in cases of erroneous therapeutic management of malignant bone tumors].

Kaczurba M, Grzesiakowska U.

Nowotwory. 1979;Suppl:101-3. Polish. No abstract available.

PMID:
295453
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk